 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular matrix
|
1 term
|
 |
|
Biological process
|
proteolysis
|
1 term
|
 |
|
Biochemical function
|
metallopeptidase activity
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
292:837-844
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of recombinant mouse collagenase-3 (MMP-13).
|
|
I.Botos,
E.Meyer,
S.M.Swanson,
V.Lemaître,
Y.Eeckhout,
E.F.Meyer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The matrix metalloproteinases are crucial in the physiological and pathological
degradation of the mammalian extracellular matrix, including breast tumours, and
osteoarthritic cartilage. These enzymes are classified according to their matrix
substrate specificity. Collagenase-3 (MMP-13) is a member of this family and
preferentially cleaves type II collagen, cartilage, fibronectin and aggrecan.
Collagenase-3 is normally expressed in hypertrophic chondrocytes, periosteal
cells, and osteoblasts during bone development. The structure of the catalytic
domain of recombinant mouse collagenase-3, complexed to the hydroxamate
inhibitor (RS-113456), is reported at 2.0 A resolution. Molecular replacement
and weak phasing information from a single derivative determined the structure.
Neither molecular replacement nor derivative methods had a sufficient radius of
convergence to yield a refinable structure. The structure illuminates the atomic
zinc ion interactions with functional groups in the active site, emphasizing
zinc ligation and the very voluminous hydrophobic P1' group for the inhibitor
potency. The structure provides insight into the specificity of this enzyme,
facilitating design of specific inhibitors to target various diseases.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Ribbon diagram of collagenase-3 with the
catalytic and structural zinc atoms (blue spheres), the
structural calcium atoms (red spheres) and the bound RS-113456
inhibitor. Figure created with SPOCK [Christopher 1998] and
rendered with Raster-3D [Bacon and Anderson 1988 and Merritt and
Murphy 1994].
|
 |
Figure 3.
Figure 3. Stereo view of active site region with the
catalytic zinc atom (blue sphere), ligating histidine residues
and bound inhibitor. Omit map contoured at 2.0 s. Figure created
with SPOCK.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1999,
292,
837-844)
copyright 1999.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.H.Penhoat,
Z.Li,
H.S.Atreya,
S.Kim,
A.Yee,
R.Xiao,
D.Murray,
C.H.Arrowsmith,
and
T.Szyperski
(2005).
NMR solution structure of Thermotoga maritima protein TM1509 reveals a Zn-metalloprotease-like tertiary structure.
|
| |
J Struct Funct Genomics, 6,
51-62.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|